Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in the generic pharmaceutical sector. Sandoz employs over 26,500 employees and its products are available in more than 160 countries, offering a broad range of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of approximately 1,100 molecules already available to more than 90% of the world’s population and continues to work hard to further increase global access. Sandoz holds the #1 position globally in biosimilars as well as in generic injectables, ophthalmics, dermatology and antibiotics, complemented by leading positions in the cardiovascular, metabolism, central nervous system, pain, gastrointestinal, respiratory, and hormonal therapeutic areas. Since year 1991 we are present in Croatia as company Lek. In year 2002 we became a member of a Sandoz company, and finally in 2010. we are Sandoz, a Novartis company. We live Sandoz values and are proud that we provide patients across Croatia with high-quality, affordable Sandoz products.